Page last updated: 2024-11-07

maltotetraose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp : A maltotetraose tetrasaccharide consisting of three alpha-D-glucopyranose residues and a D-glucopyranose residue joined in sequence by (1->4) glycosidic bonds. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439639
CHEBI ID143180
MeSH IDM0054853

Synonyms (24)

Synonym
C02052
34612-38-9
MALTOTETRAOSE ,
amylotetraose
d-maltotetraose
alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranosyl-(1->4)-d-glucopyranose
o-alpha-d-glucopyranosyl-(1->4)-o-alpha-d-glucopyranosyl-(1->4)-o-alpha-d-glucopyranosyl-(1->4)-d-glucose
CHEBI:143180
alpha-d-gluco-hexopyranosyl-(1->4)-alpha-d-gluco-hexopyranosyl-(1->4)-alpha-d-gluco-hexopyranosyl-(1->4)-d-gluco-hexopyranose
glc(a1-4)glc(a1-4)glc(a1-4)glc
(3r,4r,5s,6r)-5-{[(2r,3r,4r,5s,6r)-5-{[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,3,4-triol
alpha-d-glcp-(1->4)-alpha-d-glcp-(1->4)-alpha-d-glcp-(1->4)-d-glcp
o-alpha-d-glucopyranosyl-(1->4)-o(4xi)-alpha-d-xylo-hexopyranosyl-(1->4)-o-alpha-d-glucopyranosyl-(1->4)-d-glucose
o-alpha-delta-glucopyranosyl-(1->4)-o(4xi)-alpha-delta-xylo-hexopyranosyl-(1->4)-o-alpha-delta-glucopyranosyl-(1->4)-delta-glucose
o-alpha-d-glucopyranosyl-(1-4)-o-alpha-d-glucopyranosyl-(1-4)-o-alpha-d-glucopyranosyl-(1-4)-d-glucose
o-alpha-delta-glucopyranosyl-(1-4)-o-alpha-delta-glucopyranosyl-(1-4)-o-alpha-delta-glucopyranosyl-(1-4)-delta-glucose
o-alpha-delta-glucopyranosyl-(1.4)-o-alpha-delta-glucopyranosyl-(1.4)-o-alpha-delta-glucopyranosyl-(1.4)-delta-glucose
fujioligo 450
a-1,4-tetraglucose
A858328
1263-76-9
o-alpha-d-glucopyranosyl-(1-->4)-o-alpha-d-glucopyranosyl-(1-->4)-o-alpha-d-glucopyranosyl-(1-->4)-d-glucopyranose
DTXSID101021048
AKOS040758810
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
maltotetraose tetrasaccharideA glucotetrose in which the four D-glucose residues are connected by alpha(1->4) linkages.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
glycogen degradation I850
glycogen catabolism05

Research

Studies (85)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (16.47)18.7374
1990's32 (37.65)18.2507
2000's21 (24.71)29.6817
2010's14 (16.47)24.3611
2020's4 (4.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.14%)5.53%
Reviews1 (1.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other86 (97.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]